Stock-Based Comp
Agilent Technologies Stock-Based Comp increased by 57.7% to $41.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.5%, from $40.00M to $41.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 3.9% CAGR.
Analysis
How to read this metric
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Detailed definition
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
Peer comparison
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
stock_based_compensationHistorical Data
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.00M | $22.00M | $22.00M | $44.00M | $27.00M | $28.00M | $26.00M | $44.00M | $24.00M | $29.00M | $14.00M | $44.00M | $31.00M | $28.00M | $26.00M | $40.00M | $30.00M | $32.00M | $26.00M | $41.00M |
| QoQ Change | — | -15.4% | +0.0% | +100.0% | -38.6% | +3.7% | -7.1% | +69.2% | -45.5% | +20.8% | -51.7% | +214.3% | -29.5% | -9.7% | -7.1% | +53.8% | -25.0% | +6.7% | -18.8% | +57.7% |
| YoY Change | — | — | — | — | +3.8% | +27.3% | +18.2% | +0.0% | -11.1% | +3.6% | -46.2% | +0.0% | +29.2% | -3.4% | +85.7% | -9.1% | -3.2% | +14.3% | +0.0% | +2.5% |
Business Segments
| Segment | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Agilent CrossLab | $6.00M | $6.00M | $7.25M | $7.25M | $7.25M | $7.25M | $16.00M | $16.00M |
| Diagnostics and Genomics | $5.50M | $5.50M | $7.50M | $7.50M | $7.50M | — | — | — |
| Life Sciences and Applied Markets | $16.50M | $16.50M | $14.75M | $14.75M | $14.75M | — | — | — |
| Total | $29.00M | $14.00M | $44.00M | $31.00M | $28.00M | $26.00M | $40.00M | $41.00M |
Diagnostics and Genomics, Life Sciences and Applied Markets are derived from annual filings.
Diagnostics and Genomics, Life Sciences and Applied Markets were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's stock-based comp?
- Agilent Technologies (A) reported stock-based comp of $41.00M in Q4 2025.
- How has Agilent Technologies's stock-based comp changed year-over-year?
- Agilent Technologies's stock-based comp increased by 2.5% year-over-year, from $40.00M to $41.00M.
- What is the long-term trend for Agilent Technologies's stock-based comp?
- Over 4 years (2021 to 2025), Agilent Technologies's stock-based comp has grown at a 3.9% compound annual growth rate (CAGR), from $110.00M to $128.00M.
- What does stock-based comp mean?
- The value of company shares given to employees as part of their pay.